These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22150535)

  • 41. Comparison of QD and TID oral mesalazine for maintenance of remission in quiescent ulcerative colitis: a double-blind, double-dummy, randomized multicenter study.
    Watanabe M; Hanai H; Nishino H; Yokoyama T; Terada T; Suzuki Y
    Inflamm Bowel Dis; 2013 Jul; 19(8):1681-90. PubMed ID: 23624890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Ake Nilsson.
    Nilsson A
    Drugs; 2007; 67(17):2643-4. PubMed ID: 18034596
    [No Abstract]   [Full Text] [Related]  

  • 43. Mesalamine with MMX technology for the treatment of ulcerative colitis.
    Schreiber S; Kamm MA; Lichtenstein GR
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
    Kruis W; Fric P; Pokrotnieks J; Lukás M; Fixa B; Kascák M; Kamm MA; Weismueller J; Beglinger C; Stolte M; Wolff C; Schulze J
    Gut; 2004 Nov; 53(11):1617-23. PubMed ID: 15479682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
    Rubin DT; Bradette M; Gabalec L; Dobru D; Márquez J; Inglis S; Magee E; Solomon D; D'Haens G;
    J Crohns Colitis; 2016 Aug; 10(8):925-33. PubMed ID: 26908939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine.
    García-Morán S; Sáez-Royuela F; Pérez-Alvarez JC; Gento E; Téllez J
    Inflamm Bowel Dis; 2006 Apr; 12(4):334-5. PubMed ID: 16633055
    [No Abstract]   [Full Text] [Related]  

  • 47. Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Cosimo Prantera.
    Prantera C
    Drugs; 2007; 67(17):2643-4. PubMed ID: 18034595
    [No Abstract]   [Full Text] [Related]  

  • 48. Once-daily mesalamine granules for ulcerative colitis.
    Lawlor G; Ahmed A; Moss AC
    Expert Rev Clin Immunol; 2010 Jul; 6(4):521-6. PubMed ID: 20594123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
    Raedler A; Behrens C; Bias P
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1353-63. PubMed ID: 15606398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
    Bello C; Belaiche J; Louis E; Reenaers C
    J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.
    Langhorst J; Varnhagen I; Schneider SB; Albrecht U; Rueffer A; Stange R; Michalsen A; Dobos GJ
    Aliment Pharmacol Ther; 2013 Sep; 38(5):490-500. PubMed ID: 23826890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
    Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M
    Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesalazine for the treatment of inflammatory bowel disease.
    Criscuoli V; Modesto I; Orlando A; Cottone M
    Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decision tree construction and cost-effectiveness analysis of treatment of ulcerative colitis with pentasa® mesalazine 2 g sachet.
    Nishikawa AM; Paladini L; Delfini R; Kotze PG; Clark O
    Arq Gastroenterol; 2013; 50(4):297-303. PubMed ID: 24474233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].
    MMW Fortschr Med; 2004 Jun; 146(24):53. PubMed ID: 15366501
    [No Abstract]   [Full Text] [Related]  

  • 57. Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis.
    Carmody JK; Plevinsky J; Peugh JL; Denson LA; Hyams JS; Lobato D; LeLeiko NS; Hommel KA
    Aliment Pharmacol Ther; 2019 Oct; 50(8):911-918. PubMed ID: 31373712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How important is mesalamine in the maintenance of steroid-refractory colitis?
    Actis GC; Marzano A; Pellicano R; Rizzetto M
    Inflamm Bowel Dis; 2008 Jul; 14(7):1026. PubMed ID: 18338772
    [No Abstract]   [Full Text] [Related]  

  • 59. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

  • 60. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).
    Fernández-Bañares F; Hinojosa J; Sánchez-Lombraña JL; Navarro E; Martínez-Salmerón JF; García-Pugés A; González-Huix F; Riera J; González-Lara V; Domínguez-Abascal F; Giné JJ; Moles J; Gomollón F; Gassull MA
    Am J Gastroenterol; 1999 Feb; 94(2):427-33. PubMed ID: 10022641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.